Annual financial news and ad hoc releases
In our archive you will find financial news since 2005
Offenburg, February 20, 2015 – MEDICLIN Aktiengesellschaft (MediClin) achieved Group sales of EUR 538.0 mill. in the 2014 FY. The sales plus was EUR 23.1 mill. or 4.5 % against previous year. The largest share of sales growth – about eighty percent – accounted for the post-acute segment, which had not to face the usual seasonal slowdown of occupancy in the 1st. and 4th quarter 2014. The occupancy rate of the Group rose from 84.7 % to 87.3 %. The number of cases increased 1.8 % to almost 121 thousand cases.
The preliminary Group operating result (Group-EBIT) increased from EUR 2.2 mill. to EUR 15.6 mill. and the preliminary result attributable to shareholders from EUR -2.6 mill. to EUR 8.5 mill. Earnings per share account to EUR 0.18 (previous year: EUR -0.06).
EUR 21.0 mill (previous year: EUR 18.6 mill.) were invested in capital expenditure in the 2014 FY including EUR 5.2 mill. (previous year: EUR 4.4 mill.) subsidies. As of December 31, 2014 cash and cash equivalents amount to EUR 26.3 mill. (31.12.2013: EUR 13.2 mill.); the equity ratio is 48.2 %.
The press conference and the analysts and investor conference will take place in Frankfurt on March 19, 2015. From that date onwards the annual report 2014 will be available under www.mediclin.de.
Preliminary figures – quarterly development and yoy comparison of the Group and the segments
About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services in the area of Psycho- and Neuro-sciences as well as Orthopaedic. With 34 clinics and 7 nursing care facilities and 8 medical care centres in 11 federal states MediClin has a total capacity of approximately 8,000 beds. MediClins’ facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 8,800 employees.